Pretransplant Antifibrotic Therapy Is Associated with Resolution of Primary Graft Dysfunction

Ann Am Thorac Soc. 2022 Feb;19(2):335-338. doi: 10.1513/AnnalsATS.202106-736RL.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Primary Graft Dysfunction*